Originally published May 13.

NEW YORK (GenomeWeb) — Genomic Health said that it anticipates continued adoption of its flagship Oncotype DX breast cancer test outside the US this year, and it is planning to share several studies in coming months supporting the expanded use of that test. Company officials also discussed during a call describing first quarter earnings last week efforts to build the evidence base for, and drive adoption of, its new prostate cancer diagnostic.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.